Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Sera Prognostics, Inc. (SERA)
USD2.17
+0.19 (+9.60%)
US NASDAQ Healthcare Medical - Diagnostics & Research
Address
2749 East Parleys Way 84109
Salt Lake City, UT, US
Salt Lake City, UT, US
CEO
Zhenya Lindgardt
Website
seraprognostics.com
IPO
2021-07-15
CIK 1534969 ISIN US81749D1072
Description
Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present. Additionally, the company is cultivating a portfolio of potential tests for various other pregnancy-related conditions, such as preeclampsia, predicting time-to-birth at a molecular level, gestational diabetes mellitus, restricted fetal growth, stillbirth, and postpartum depression. Established in 2008, the organization's main operations are based in Salt Lake City, Utah.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD2.17
+0.19 (+9.60%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
51.1K
Beta
0.94
Float Shares
27.57M
Free Float %
72.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.31% | -10.11% | -20.66% | -36.23% | -42.71% | -42.71% | -28.09% | -50.73% | -85.80% | -85.80% | -85.80% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (5 ratings, all time)
Buy
Price Targets & DCF
Current price
2.17
Low
5.00
+130.4%
Consensus
5.00
+130.4%
Median
5.00
+130.4%
High
5.00
+130.4%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 1 |
5.00
+130.4%
|
| All Time | 1 |
5.00
+130.4%
|
Quality scores
Altman Z-Score
-3.96
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Diagnostics & Research: +7.9%+5.2% Q1'26: -63.2% (vs Q1'25)
-
EPS growth Medical - Diagnostics & Research: +30.8%+32.3% ★ Q1'26: +15.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%-45,487.7% Q1'26: -62,728.6% (vs Q1'25)
-
EBIT margin Medical - Diagnostics & Research: +9.6%-45,066.7% Q1'26: -66,857.1% (vs Q1'25)
-
ROIC Medical - Diagnostics & Research: +5.2%-94.7% Q1'26: -164.8% (vs Q1'25)
-
Share dilution Medical - Diagnostics & Research: 0.0%+43.8% Q1'26: +19.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×-0.07× Q1'26: -0.07× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
82.0K
est: 193.1K (-57.5%)
|
268.0K
est: 361.8K (-25.9%)
|
306.0K
est: 107.0K (+186.0%)
|
77.0K
est: 110.0K (-30.0%)
|
81.0K
est: 99.1K (-18.3%)
|
415.3K
207.7K – 623.0K
+319.1% YoY
|
3.09M
2.09M – 4.08M
+643.6% YoY
|
9.12M
4.06M – 14.18M
+195.4% YoY
|
19.30M
8.60M – 30.00M
+111.6% YoY
|
35.70M
15.90M – 55.50M
+85.0% YoY
|
| EBITDA |
-33.60M
est: -193.1K (-17,305.4%)
|
-43.37M
est: -361.8K (-11,887.8%)
|
-35.29M
est: -107.0K (-32,878.5%)
|
-32.04M
est: -110.0K (-29,024.5%)
|
-35.56M
est: -99.1K (-35,787.0%)
|
-415.3K
-623.0K – -207.7K
-319.1% YoY
|
-3.09M
-4.08M – -2.09M
-643.6% YoY
|
-9.12M
-14.18M – -4.06M
-195.4% YoY
|
-19.30M
-30.00M – -8.60M
-111.6% YoY
|
-35.70M
-55.50M – -15.90M
-85.0% YoY
|
| EBIT |
-34.26M
est: -193.1K (-17,646.7%)
|
-44.13M
est: -361.8K (-12,096.7%)
|
-36.19M
est: -107.0K (-33,719.6%)
|
-32.87M
est: -110.0K (-29,781.8%)
|
-36.50M
est: -99.1K (-36,735.5%)
|
-415.3K
-623.0K – -207.7K
-319.1% YoY
|
-3.09M
-4.08M – -2.09M
-643.6% YoY
|
-9.12M
-14.18M – -4.06M
-195.4% YoY
|
-19.30M
-30.00M – -8.60M
-111.6% YoY
|
-35.70M
-55.50M – -15.90M
-85.0% YoY
|
| Net Income |
-35.01M
est: -43.55M (+19.6%)
|
-44.19M
est: -41.57M (-6.3%)
|
-36.24M
est: -31.54M (-14.9%)
|
-32.90M
est: -32.99M (+0.3%)
|
-31.93M
est: -37.83M (+15.6%)
|
-40.84M
-53.59M – -8.69M
-7.9% YoY
|
-42.10M
-45.05M – -7.30M
-3.1% YoY
|
-24.72M
-42.55M – -6.90M
+41.3% YoY
|
-27.17M
-46.75M – -7.58M
-9.9% YoY
|
-18.59M
-31.99M – -5.19M
+31.6% YoY
|
| SGA |
24.42M
est: 45.89M (-46.8%)
|
31.48M
est: 86.00M (-63.4%)
|
24.69M
est: 22.84M (+8.1%)
|
21.90M
est: 23.48M (-6.7%)
|
23.25M
est: 21.16M (+9.9%)
|
88.67M
44.33M – 133.00M
+319.1% YoY
|
659.36M
447.03M – 871.70M
+643.6% YoY
|
1.95B
867.51M – 3.03B
+195.4% YoY
|
4.12B
1.84B – 6.41B
+111.6% YoY
|
7.62B
3.39B – 11.85B
+85.0% YoY
|
| EPS |
-1.18
est: -1.31 (+10.2%)
|
-1.43
est: -1.48 (+3.7%)
|
-1.16
est: -0.99 (-17.6%)
|
-0.99
est: -0.98 (-1.5%)
|
-0.67
est: -0.70 (+4.5%)
|
-0.65
-1.12 – -0.18
+6.9% YoY
|
-0.55
-0.95 – -0.15
+15.9% YoY
|
-0.52
-0.89 – -0.14
+5.5% YoY
|
-0.57
-0.98 – -0.16
-9.9% YoY
|
-0.39
-0.67 – -0.11
+31.6% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-28.48M
OE per share TTM
-0.57
Owner's Yield
-31.30%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
1,556.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
10
Total invested
11.02M
Insider transactions (90d)
0
Beneficial owners (>5%)
28
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Baker Bros. Advisors (GP) LLC | 5.43M | 17.90% | 5.43M | — | 5.43M | — | HC, OO | Delaware | 2024-01-10 | ↗ |
| 2 | Baker Bros. Advisors LP | 5.43M | 17.90% | 5.43M | — | 5.43M | — | IA, PN | Delaware | 2024-01-10 | ↗ |
| 3 | Felix J. Baker | 5.43M | 17.90% | 5.43M | — | 5.43M | — | HC, IN | Delaware | 2024-01-10 | ↗ |
| 4 | Julian C. Baker | 5.43M | 17.90% | 5.43M | — | 5.43M | — | HC, IN | Delaware | 2024-01-10 | ↗ |
| 5 | ATH Holding Company, LLC | 3.20M | 10.10% | — | 3.20M | — | 3.20M | OO | Indiana | 2022-02-22 | ↗ |
| 6 | Anthem, Inc. | 3.20M | 10.10% | — | 3.20M | — | 3.20M | CO | Indiana | 2022-02-22 | ↗ |
| 7 | Gilbert H. Kliman (a Managing Director of InterWest Management Partners X, LLC) | 2.54M | 8.60% | — | 2.54M | — | 2.54M | IN | — | 2022-02-14 | ↗ |
| 8 | InterWest Management Partners X, LLC (the General Partner of InterWest Partners X, LP) | 2.54M | 8.60% | 2.54M | — | 2.54M | — | OO | — | 2022-02-14 | ↗ |
| 9 | InterWest Partners X, LP (“IWP X”) | 2.54M | 8.60% | 2.54M | — | 2.54M | — | PN | — | 2022-02-14 | ↗ |
| 10 | Keval Desai (a Venture Member of InterWest Management Partners X, LLC) | 2.54M | 8.60% | — | 2.54M | — | 2.54M | IN | — | 2022-02-14 | ↗ |
| 11 | Khaled A. Nasr (a Venture Member of InterWest Management Partners X, LLC) | 2.54M | 8.60% | — | 2.54M | — | — | IN | — | 2022-02-14 | ↗ |
| 12 | Domain Partners VIII, L.P. | 2.52M | 8.60% | 2.52M | — | 2.52M | — | PN | Delaware | 2022-01-04 | ↗ |
| 13 | s | 2.05M | 6.50% | — | 2.05M | — | — | HC, IN | Delaware | 2024-04-01 | ↗ |
| 14 | Dr. Yair C. Schindel | 1.92M | 6.20% | — | 1.92M | — | 1.92M | IN | Cayman Islands | 2022-01-24 | ↗ |
| 15 | aMoon General Partner Ltd. | 1.92M | 6.20% | — | 1.92M | — | 1.92M | CO | Cayman Islands | 2022-01-24 | ↗ |
| 16 | aMoon Growth Fund G.P. Limited Partnership | 1.92M | 6.20% | — | 1.92M | — | 1.92M | PN | Cayman Islands | 2022-01-24 | ↗ |
| 17 | aMoon Growth Fund Limited Partnership | 1.92M | 6.20% | — | 1.92M | — | 1.92M | PN | Cayman Islands | 2022-01-24 | ↗ |
| 18 | Vivo Capital IX, LLC | 1.86M | 6.40% | 1.86M | — | 1.86M | — | OO | Delaware | 2021-07-23 | ↗ |
| 19 | Domain Associates, LLC | 30.9K | 0.10% | 30.9K | — | 30.9K | — | PN | Delaware | 2022-01-04 | ↗ |
| 20 | DP VIII Associates, L.P. | 18.7K | 0.10% | 18.7K | — | 18.7K | — | PN | Delaware | 2022-01-04 | ↗ |
| 21 | BXHCP SP II, LLC | — | 3.40% | — | 1.01M | — | 1.01M | OO | Delaware | 2022-07-19 | ↗ |
| 22 | BXHCP SP III, LLC | — | 3.40% | — | 1.01M | — | 1.01M | OO | Delaware | 2022-07-19 | ↗ |
| 23 | Blue Ox Healthcare Partners SP, LLC | — | 3.40% | — | 1.01M | — | 1.01M | OO | Delaware | 2022-07-19 | ↗ |
| 24 | Blue Ox Healthcare Partners, LLC | — | 3.40% | — | 1.01M | — | 1.01M | OO | Delaware | 2022-07-19 | ↗ |
| 25 | Blue Ox Healthcare Partners, LLC Blue Ox Healthcare Partners SP, L | — | 3.40% | — | 1.01M | — | 1.01M | OO | Delaware | 2022-07-19 | ↗ |
| 26 | Charles D. Kennedy MD | — | 3.40% | — | 1.01M | — | 1.01M | IN | Delaware | 2022-07-19 | ↗ |
| 27 | John A. Neczesny | — | 3.40% | — | 1.01M | — | 1.01M | IN | Delaware | 2022-07-19 | ↗ |
| 28 | Oded Levy | — | 3.40% | — | 1.01M | — | 1.01M | IN | Delaware | 2022-07-19 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
10
-46 vs prev Q
New positions
2
Closed positions
48
Increased
3
Reduced
2
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | 5.50M +— (+0.0%) | 16.22M -604.8K (-3.6%) | 11.10% -0.104 pp | 0.10% -0.027 pp | USD5.59 -47.2% | 18 qtrs — |
| 2 | WHETSTONE CAPITAL ADVISORS, LLC | 3.46M -172.7K (-4.8%) | 10.21M -908.9K (-8.2%) | 6.99% -0.417 pp | 3.18% +0.106 pp | USD2.77 +6.5% | 3 qtrs — |
| 3 | ABRDN PLC | 2.28M +— (+0.0%) | 6.73M -250.8K (-3.6%) | 4.60% -0.043 pp | 0.01% -0.001 pp | USD3.27 -9.8% | 4 qtrs — |
| 4 | VIVO CAPITAL, LLC | 1.65M +— (+0.0%) | 4.87M -181.5K (-3.6%) | 3.33% -0.031 pp | 0.31% -0.092 pp | USD11.11 -73.4% | 18 qtrs — |
| 5 | VANGUARD GROUP INC | 1.24M +22.3K (+1.8%) | 3.66M -68.2K (-1.8%) | 2.50% +0.022 pp | 0.00% +0.000 pp | USD5.42 -45.6% | 18 qtrs — |
| 6 | CITADEL ADVISORS LLC | 707.6K +53.9K (+8.2%) | 2.09M +87.0K (+4.3%) | 1.43% +0.096 pp | 0.00% +0.000 pp | USD3.60 -18.1% | 7 qtrs — |
| 7 | CAPTRUST FINANCIAL ADVISORS | 536.8K -65.6K (-10.9%) | 1.58M -259.7K (-14.1%) | 1.08% -0.144 pp | 0.00% -0.001 pp | USD2.55 +15.7% | 14 qtrs — |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 334.6K +3.5K (+1.1%) | 987.5K -26.1K (-2.6%) | 0.68% +0.001 pp | 0.00% +0.000 pp | USD5.05 -41.6% | 18 qtrs — |
| 9 | AWM INVESTMENT COMPANY, INC. | 207.4K +— (+0.0%) | 611.8K -22.8K (-3.6%) | 0.42% -0.004 pp | 0.06% 0.000 pp | USD6.12 -51.8% | 9 qtrs — |
| 10 | BLACKROCK, INC. | 186.8K +7.8K (+4.3%) | 550.9K +3.2K (+0.6%) | 0.38% +0.012 pp | 0.00% +0.000 pp | USD6.75 -56.3% | 6 qtrs — |
| 11 | STATE STREET CORP | 124.8K +— (+0.0%) | 368.1K -13.7K (-3.6%) | 0.25% -0.002 pp | 0.00% +0.000 pp | USD5.80 -49.1% | 12 qtrs — |
| 12 | MILLENNIUM MANAGEMENT LLC | 113.2K -14.1K (-11.1%) | 333.9K -55.6K (-14.3%) | 0.23% -0.031 pp | 0.00% +0.000 pp | USD3.40 -13.2% | 8 qtrs — |
| 13 | GSA CAPITAL PARTNERS LLP | 107.2K +42.0K (+64.5%) | 316.0K +117.0K (+58.8%) | 0.22% +0.084 pp | 0.03% +0.011 pp | USD3.08 -4.2% | 4 qtrs — |
| 14 | CI PRIVATE WEALTH, LLC | 100.0K +— (+0.0%) | 290.0K -16.0K (-5.2%) | 0.20% -0.002 pp | 0.00% 0.000 pp | USD4.40 -33.0% | 9 qtrs — |
| 15 | NORTHERN TRUST CORP | 96.5K +8.1K (+9.1%) | 284.8K +14.0K (+5.2%) | 0.19% +0.015 pp | 0.00% +0.000 pp | USD6.82 -56.7% | 18 qtrs — |
| 16 | MORGAN STANLEY | 81.0K -3.0K (-3.6%) | 238.9K -18.2K (-7.1%) | 0.16% -0.008 pp | 0.00% +0.000 pp | USD7.25 -59.3% | 18 qtrs — |
| 17 | BANK OF NEW YORK MELLON CORP | 75.3K +— (+0.0%) | 222.0K -8.3K (-3.6%) | 0.15% -0.001 pp | 0.00% +0.000 pp | USD5.78 -49.0% | 12 qtrs — |
| 18 | PERIGON WEALTH MANAGEMENT, LLC | 72.7K +— (+0.0%) | 214.4K -8.0K (-3.6%) | 0.15% -0.001 pp | 0.00% -0.001 pp | USD5.98 -50.7% | 9 qtrs — |
| 19 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 71.5K +49.2K (+219.7%) | 211.0K +142.6K (+208.2%) | 0.14% +0.099 pp | 0.00% +0.000 pp | USD4.57 -35.4% | 14 qtrs — |
| 20 | JANE STREET GROUP, LLC | 68.8K +68.8K (+100.0%) | 203.0K +203.0K (+100.0%) | 0.14% +0.139 pp | 0.00% +0.000 pp | USD2.95 +0.0% | 1 qtrs NEW |
| 21 | REQUISITE CAPITAL MANAGEMENT, LLC | 55.6K +— (+0.0%) | 164.2K -6.1K (-3.6%) | 0.11% -0.001 pp | 0.03% +0.003 pp | USD3.83 -23.0% | 14 qtrs — |
| 22 | TWELVE POINTS WEALTH MANAGEMENT LLC | 43.4K +— (+0.0%) | 160.1K +27.3K (+20.6%) | 0.09% -0.001 pp | 0.04% +0.003 pp | USD6.04 -51.2% | 7 qtrs — |
| 23 | BALLENTINE PARTNERS, LLC | 49.7K +— (+0.0%) | 146.5K -5.5K (-3.6%) | 0.10% -0.001 pp | 0.00% 0.000 pp | USD6.04 -51.2% | 7 qtrs — |
| 24 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 45.7K +— (+0.0%) | 134.8K -5.0K (-3.6%) | 0.09% -0.001 pp | 0.00% 0.000 pp | USD3.57 -17.4% | 12 qtrs — |
| 25 | HIGHTOWER ADVISORS, LLC | 42.2K +— (+0.0%) | 124.6K -4.6K (-3.6%) | 0.09% -0.001 pp | 0.00% +0.000 pp | USD9.34 -68.4% | 8 qtrs — |
| 26 | BARCLAYS PLC | 36.7K -2.7K (-6.9%) | 108.3K -199.4K (-64.8%) | 0.07% -0.006 pp | 0.00% 0.000 pp | USD3.06 -3.6% | 7 qtrs — |
| 27 | SQUAREPOINT OPS LLC | 36.3K -56.7K (-61.0%) | 107.2K -177.6K (-62.4%) | 0.07% -0.116 pp | 0.00% 0.000 pp | USD3.92 -24.7% | 5 qtrs — |
| 28 | QUBE RESEARCH & TECHNOLOGIES LTD | 29.0K +4.9K (+20.3%) | 85.5K +11.8K (+16.0%) | 0.06% +0.009 pp | 0.00% +0.000 pp | USD2.80 +5.4% | 3 qtrs — |
| 29 | GOLDMAN SACHS GROUP INC | 28.6K -26.2K (-47.8%) | 84.4K -83.4K (-49.7%) | 0.06% -0.054 pp | 0.00% +0.000 pp | USD7.62 -61.3% | 8 qtrs — |
| 30 | BIRCH HILL INVESTMENT ADVISORS LLC | 27.3K +— (+0.0%) | 80.5K -3.0K (-3.6%) | 0.06% -0.001 pp | 0.00% 0.000 pp | USD3.06 -3.6% | 2 qtrs — |
| 31 | UBS GROUP AG | 25.2K +672.0 (+2.7%) | 74.3K -715.0 (-1.0%) | 0.05% +0.001 pp | 0.00% +0.000 pp | USD3.19 -7.5% | 17 qtrs — |
| 32 | CETERA INVESTMENT ADVISERS | 25.0K +25.0K (+100.0%) | 73.8K +73.8K (+100.0%) | 0.05% +0.051 pp | 0.00% +0.000 pp | USD2.95 +0.0% | 1 qtrs NEW |
| 33 | DIMENSIONAL FUND ADVISORS LP | 22.9K +510.0 (+2.3%) | 67.5K -1.1K (-1.6%) | 0.05% +0.001 pp | 0.00% +0.000 pp | USD7.38 -60.0% | 12 qtrs — |
| 34 | TWO SIGMA INVESTMENTS, LP | 22.0K -9.8K (-30.8%) | 64.8K -32.3K (-33.3%) | 0.04% -0.020 pp | 0.00% 0.000 pp | USD3.06 -3.6% | 2 qtrs — |
| 35 | LIDO ADVISORS, LLC | 16.6K -5.5K (-25.0%) | 50.3K -17.6K (-25.9%) | 0.03% -0.012 pp | 0.00% 0.000 pp | USD3.06 -3.6% | 2 qtrs — |
| 36 | FMR LLC | 14.8K +— (+0.0%) | 43.8K -1.6K (-3.6%) | 0.03% 0.000 pp | 0.00% +0.000 pp | USD3.65 -19.2% | 6 qtrs — |
| 37 | WAGNER WEALTH MANAGEMENT, LLC | 12.7K +286.0 (+2.3%) | 37.4K -520.0 (-1.4%) | 0.03% +0.000 pp | 0.01% -0.001 pp | USD2.77 +6.5% | 3 qtrs — |
| 38 | RIVERVIEW CAPITAL ADVISERS, LLC | 12.7K -64.0 (-0.5%) | 37.4K -1.6K (-4.1%) | 0.03% 0.000 pp | 0.01% +0.000 pp | USD2.77 +6.5% | 3 qtrs — |
| 39 | COLONY GROUP, LLC | 12.2K +— (+0.0%) | 35.9K -1.3K (-3.6%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD8.14 -63.8% | 7 qtrs — |
| 40 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 12.1K -7.0 (-0.1%) | 35.7K -1.4K (-3.7%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD5.82 -49.3% | 12 qtrs — |
| 41 | POINT72 ASSET MANAGEMENT, L.P. | 11.4K +11.4K (+100.0%) | 33.6K +33.6K (+100.0%) | 0.02% +0.023 pp | 0.00% +0.000 pp | USD2.95 +0.0% | 1 qtrs NEW |
| 42 | ABEL HALL, LLC | 11.0K +— (+0.0%) | 32.6K -1.2K (-3.6%) | 0.02% 0.000 pp | 0.01% -0.006 pp | USD2.77 +6.5% | 3 qtrs — |
| 43 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 10.6K +10.6K (+100.0%) | 31.5K +31.5K (+100.0%) | 0.02% +0.022 pp | 0.00% +0.000 pp | USD2.95 +0.0% | 5 qtrs — |
| 44 | DEUTSCHE BANK AG\ | 8.7K +— (+0.0%) | 25.8K -960.0 (-3.6%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD8.10 -63.6% | 7 qtrs — |
| 45 | GENEOS WEALTH MANAGEMENT INC. | 7.8K +3.3K (+73.3%) | 23.0K +9.2K (+67.1%) | 0.02% +0.007 pp | 0.00% +0.000 pp | USD3.01 -2.0% | 2 qtrs — |
| 46 | BANK OF AMERICA CORP /DE/ | 4.7K -774.0 (-14.2%) | 13.8K -2.9K (-17.3%) | 0.01% -0.002 pp | 0.00% +0.000 pp | USD5.59 -47.2% | 9 qtrs — |
| 47 | CWM, LLC | 1.0K -1.0 (-0.1%) | 3.0K +— (+0.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.76 -48.8% | 9 qtrs — |
| 48 | TOWER RESEARCH CAPITAL LLC (TRC) | 945.00 +945.0 (+100.0%) | 2.8K +2.8K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD2.95 +0.0% | 8 qtrs — |
| 49 | OPTIVER HOLDING B.V. | 412.00 +— (+0.0%) | 1.2K -46.0 (-3.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.06 -3.6% | 2 qtrs — |
| 50 | — | 389.00 +389.0 (+100.0%) | 1.1K +1.1K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.001 pp | USD2.95 +0.0% | 1 qtrs NEW |
| 51 | FORTITUDE FAMILY OFFICE, LLC | 301.00 +— (+0.0%) | 888.00 -33.0 (-3.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.06 -3.6% | 2 qtrs — |
| 52 | BNP PARIBAS ARBITRAGE, SNC | 236.00 +— (+0.0%) | 696.00 -26.0 (-3.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD8.14 -63.8% | 5 qtrs — |
| 53 | JPMORGAN CHASE & CO | 222.00 +— (+0.0%) | 655.00 -24.0 (-3.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.16 -52.1% | 18 qtrs — |
| 54 | CITIGROUP INC | 200.00 +195.0 (+3,900.0%) | 590.00 +575.0 (+3,833.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.06 -3.6% | 9 qtrs — |
| 55 | NISA INVESTMENT ADVISORS, LLC | 129.00 +— (+0.0%) | 381.00 -14.0 (-3.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.74 -37.8% | 6 qtrs — |
| 56 | SBI SECURITIES CO., LTD. | 7.00 -1.0 (-12.5%) | 21.00 -3.0 (-12.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.29 -44.2% | 5 qtrs — |
| 57 | BALENTINE LLC | — -84.5K (-100.0%) | — -258.5K (-100.0%) | 0.00% -0.172 pp | 0.00% -0.010 pp | USD— | 2 qtrs SOLD |
| 58 | ADVISORY SERVICES NETWORK, LLC | — -19.0 (-100.0%) | — -58.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 59 | PALLAS CAPITAL ADVISORS LLC | — -13.7K (-100.0%) | — -42.0K (-100.0%) | 0.00% -0.028 pp | 0.00% -0.002 pp | USD— | 5 qtrs SOLD |
| 60 | SANDERS MORRIS HARRIS LLC | — -263.6K (-100.0%) | — -806.6K (-100.0%) | 0.00% -0.537 pp | 0.00% -0.107 pp | USD— | 18 qtrs SOLD |
| 61 | ROYAL BANK OF CANADA | — -2.2K (-100.0%) | — -7.0K (-100.0%) | 0.00% -0.005 pp | 0.00% +0.000 pp | USD— | 11 qtrs SOLD |
| 62 | CLIFTONLARSONALLEN WEALTH ADVISORS, LLC | — -78.9K (-100.0%) | — -241.3K (-100.0%) | 0.00% -0.161 pp | 0.00% -0.004 pp | USD— | 3 qtrs SOLD |
| 63 | CAPROCK GROUP, LLC | — -33.5K (-100.0%) | — -108.3K (-100.0%) | 0.00% -0.068 pp | 0.00% -0.003 pp | USD— | 2 qtrs SOLD |
| 64 | VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | — -12.6K (-100.0%) | — -38.4K (-100.0%) | 0.00% -0.026 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 14 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.01% | 201.6K | 0.60% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 802.7K | 0.05% |
| 3 | Avantis U.S. Small Cap Equity ETF AVSC | 0.00% | 10.6K | 0.25% |
| 4 | Dimensional - US Core Equity 1 ETF DCOR | 0.00% | 10.6K | 0.14% |
| 5 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 823.49 | 0.17% |
| 6 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 4.1K | 0.03% |
| 7 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 11.1K | 0.17% |
| 8 | Vanguard Total Stock Market ETF VTI | 0.00% | 1.91M | 0.03% |
| 9 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 4.2K | 0.22% |
| 10 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 2.3K | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.65
Neutral
Ratio by volume
3.00
Bullish
Buys
11
Sells
17
Shares acquired
698.9K
Shares disposed
86.1K
Cash buys
—
Cash sales
16.00
Net activity
+612,826
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-12 | Lindgardt Zhenya | Director / Officer | A-Award | A | Stock Option (right to buy) | 239,442 | 1.99 | 476.5K | 239,442 | D | ↗ |
| 2026-03-12 | Kearney Paul | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-03-12 | Jackson Benjamin | Officer | A-Award | A | Stock Option (right to buy) | 68,550 | 1.99 | 136.4K | 68,550 | D | ↗ |
| 2026-03-12 | Inglis Tiffany Eul Davis | Officer | A-Award | A | Stock Option (right to buy) | 27,034 | 1.99 | 53.8K | 27,034 | D | ↗ |
| 2026-03-12 | Harrison Robert Gardner | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-03-12 | Boniface John J. | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-03-12 | Anderson Dyaarl Lee Jr. | Officer | A-Award | A | Stock Option (right to buy) | 19,310 | 1.99 | 38.4K | 19,310 | D | ↗ |
| 2026-03-12 | Aerts Austin | Officer | A-Award | A | Stock Option (right to buy) | 68,550 | 1.99 | 136.4K | 68,550 | D | ↗ |
| 2026-03-11 | Lindgardt Zhenya | Director / Officer | S-Sale | D | Class A Common Stock | 2,973 | 2.04 | 6.1K | 738,314 | D | ↗ |
| 2026-03-11 | Kearney Paul | Officer | S-Sale | D | Class A Common Stock | 1,396 | 2.04 | 2.8K | 163,961 | D | ↗ |
| 2026-03-11 | Jackson Benjamin | Officer | S-Sale | D | Class A Common Stock | 1,027 | 2.04 | 2.1K | 114,720 | D | ↗ |
| 2026-03-11 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 716 | 2.04 | 1.5K | 76,712 | D | ↗ |
| 2026-03-11 | Boniface John J. | Officer | S-Sale | D | Class A Common Stock | 1,517 | 2.04 | 3.1K | 145,842 | D | ↗ |
| 2026-03-11 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 1,019 | 2.04 | 2.1K | 264,452 | D | ↗ |
| 2026-03-10 | Lindgardt Zhenya | Director / Officer | S-Sale | D | Class A Common Stock | 22,639 | 1.90 | 43.0K | 741,287 | D | ↗ |
| 2026-03-10 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 6,069 | 1.90 | 11.5K | 265,471 | D | ↗ |
| 2026-03-09 | Kearney Paul | Officer | S-Sale | D | Class A Common Stock | 2,026 | 1.96 | 4.0K | 165,357 | D | ↗ |
| 2026-03-09 | Jackson Benjamin | Officer | S-Sale | D | Class A Common Stock | 3,119 | 1.96 | 6.1K | 115,747 | D | ↗ |
| 2026-03-09 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 3,360 | 1.96 | 6.6K | 77,428 | D | ↗ |
| 2026-03-09 | Boniface John J. | Officer | S-Sale | D | Class A Common Stock | 3,038 | 1.96 | 6.0K | 147,359 | D | ↗ |
| 2026-03-09 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 674 | 1.96 | 1.3K | 271,540 | D | ↗ |
| 2026-03-06 | Lawrence Sandra AJ | Director | S-Sale | D | Class A Common Stock | 1,560 | 1.95 | 3.0K | 18,033 | D | ↗ |
| 2026-02-24 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 2,000 | 2.34 | 4.7K | 80,788 | D | ↗ |
| 2026-02-04 | Kamdar Kim P. | Director | J-Other | D | Class A Common Stock | 30,920 | 0.00 | — | 0 | I | ↗ |
| 2026-01-27 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 2,000 | 2.97 | 5.9K | 82,788 | D | ↗ |
| 2025-12-30 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 2,000 | 3.00 | 6.0K | 84,788 | D | ↗ |
| 2025-12-10 | Lindgardt Zhenya | Director / Officer | S-Sale | D | Class A Common Stock | 4,155 | 3.31 | 13.8K | 763,926 | D | ↗ |
| 2025-12-10 | Kearney Paul | Officer | S-Sale | D | Class A Common Stock | 1,213 | 3.31 | 4.0K | 167,383 | D | ↗ |
| 2025-12-10 | Jackson Benjamin | Officer | S-Sale | D | Class A Common Stock | 892 | 3.31 | 3.0K | 118,866 | D | ↗ |
| 2025-12-10 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 616 | 3.31 | 2.0K | 86,788 | D | ↗ |
| 2025-12-10 | Boniface John J. | Officer | S-Sale | D | Class A Common Stock | 1,332 | 3.31 | 4.4K | 150,397 | D | ↗ |
| 2025-12-10 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 873 | 3.31 | 2.9K | 272,214 | D | ↗ |
| 2025-12-09 | Lindgardt Zhenya | Director / Officer | S-Sale | D | Class A Common Stock | 28,215 | 3.04 | 85.8K | 768,081 | D | ↗ |
| 2025-12-09 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 5,232 | 3.04 | 15.9K | 273,087 | D | ↗ |
| 2025-12-08 | Lawrence Sandra AJ | Director | S-Sale | D | Class A Common Stock | 1,560 | 3.05 | 4.8K | 19,593 | D | ↗ |
| 2025-12-05 | Mirza Mansoor Raza | Director | S-Sale | D | Class A Common Stock | 292 | 3.05 | 890.60 | 57,740 | D | ↗ |
| 2025-12-02 | Kearney Paul | Officer | M-Exempt | A | Class A Common Stock | 32,203 | 1.62 | 52.2K | 200,799 | D | ↗ |
| 2025-12-02 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 2,000 | 2.93 | 5.9K | 87,404 | D | ↗ |
| 2025-11-26 | Kearney Paul | Officer | M-Exempt | A | Class A Common Stock | 1,986 | 1.62 | 3.2K | 170,582 | D | ↗ |
| 2025-11-10 | Lindgardt Zhenya | Director / Officer | S-Sale | D | Class A Common Stock | 11,594 | 2.62 | 30.4K | 796,296 | D | ↗ |
| 2025-11-10 | Kearney Paul | Officer | S-Sale | D | Class A Common Stock | 7,073 | 2.62 | 18.5K | 168,596 | D | ↗ |
| 2025-11-10 | Jackson Benjamin | Officer | S-Sale | D | Class A Common Stock | 7,059 | 2.62 | 18.5K | 119,758 | D | ↗ |
| 2025-11-10 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 6,528 | 2.62 | 17.1K | 89,404 | D | ↗ |
| 2025-11-10 | Boniface John J. | Officer | S-Sale | D | Class A Common Stock | 7,767 | 2.62 | 20.3K | 151,726 | D | ↗ |
| 2025-11-10 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 6,351 | 2.62 | 16.6K | 278,319 | D | ↗ |
| 2025-11-05 | Mirza Mansoor Raza | Director | S-Sale | D | Class A Common Stock | 221 | 3.04 | 671.84 | 58,032 | D | ↗ |
| 2025-11-04 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 2,000 | 3.07 | 6.1K | 95,932 | D | ↗ |
| 2025-10-15 | Inglis Tiffany Eul Davis | Officer | A-Award | A | Stock Option (right to buy) | 107,000 | 3.13 | 334.9K | 107,000 | D | ↗ |
| 2025-10-07 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 2,000 | 3.18 | 6.4K | 97,932 | D | ↗ |
| 2025-10-06 | Mirza Mansoor Raza | Director | S-Sale | D | Class A Common Stock | 227 | 3.16 | 717.32 | 58,253 | D | ↗ |
| 2025-10-01 | Inglis Tiffany Eul Davis | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-09-11 | Lindgardt Zhenya | Director / Officer | S-Sale | D | Class A Common Stock | 3,246 | 3.13 | 10.2K | 807,890 | D | ↗ |
| 2025-09-11 | Kearney Paul | Officer | S-Sale | D | Class A Common Stock | 1,271 | 3.13 | 4.0K | 175,669 | D | ↗ |
| 2025-09-11 | Jackson Benjamin | Officer | S-Sale | D | Class A Common Stock | 934 | 3.13 | 2.9K | 126,817 | D | ↗ |
| 2025-09-11 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 645 | 3.13 | 2.0K | 99,932 | D | ↗ |
| 2025-09-11 | Boniface John J. | Officer | S-Sale | D | Class A Common Stock | 1,395 | 3.13 | 4.4K | 159,493 | D | ↗ |
| 2025-09-11 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 915 | 3.13 | 2.9K | 284,670 | D | ↗ |
| 2025-09-09 | Lindgardt Zhenya | Director / Officer | S-Sale | D | Class A Common Stock | 21,158 | 3.15 | 66.6K | 811,136 | D | ↗ |
| 2025-09-09 | Lawrence Sandra AJ | Director | S-Sale | D | Class A Common Stock | 3,899 | 3.05 | 11.9K | 18,814 | D | ↗ |
| 2025-09-09 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 2,000 | 3.05 | 6.1K | 100,577 | D | ↗ |
| 2025-09-09 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 5,263 | 3.15 | 16.6K | 285,585 | D | ↗ |
| 2025-09-05 | Mirza Mansoor Raza | Director | S-Sale | D | Class A Common Stock | 222 | 3.35 | 743.70 | 58,480 | D | ↗ |
| 2025-09-02 | Kearney Paul | Officer | S-Sale | D | Class A Common Stock | 1,458 | 3.49 | 5.1K | 176,940 | D | ↗ |
| 2025-08-29 | Kearney Paul | Officer | S-Sale | D | Class A Common Stock | 10,542 | 3.49 | 36.8K | 178,398 | D | ↗ |
| 2025-08-20 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 6,000 | 2.22 | 13.3K | 102,577 | D | ↗ |
| 2025-08-08 | Lindgardt Zhenya | Director / Officer | S-Sale | D | Class A Common Stock | 8,571 | 2.54 | 21.8K | 832,294 | D | ↗ |
| 2025-08-08 | Kearney Paul | Officer | S-Sale | D | Class A Common Stock | 6,460 | 2.54 | 16.4K | 188,940 | D | ↗ |
| 2025-08-08 | Jackson Benjamin | Officer | S-Sale | D | Class A Common Stock | 6,447 | 2.54 | 16.4K | 127,751 | D | ↗ |
| 2025-08-08 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 5,962 | 2.54 | 15.1K | 108,577 | D | ↗ |
| 2025-08-08 | Boniface John J. | Officer | S-Sale | D | Class A Common Stock | 7,094 | 2.54 | 18.0K | 160,888 | D | ↗ |
| 2025-08-08 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 5,800 | 2.54 | 14.7K | 290,848 | D | ↗ |
| 2025-08-05 | Mirza Mansoor Raza | Director | S-Sale | D | Class A Common Stock | 225 | 2.50 | 562.50 | 58,702 | D | ↗ |
| 2025-07-07 | Mirza Mansoor Raza | Director | S-Sale | D | Class A Common Stock | 234 | 2.36 | 552.24 | 58,927 | D | ↗ |
| 2025-06-30 | Trimble Ryan | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-06-23 | Anderson Dyaarl Lee Jr. | Officer | A-Award | A | Class A Common Stock | 67,114 | 0.00 | — | 67,114 | D | ↗ |
| 2025-06-10 | Lindgardt Zhenya | Director / Officer | S-Sale | D | Class A Common Stock | 3,344 | 1.48 | 4.9K | 840,865 | D | ↗ |
| 2025-06-10 | Kearney Paul | Officer | S-Sale | D | Class A Common Stock | 1,311 | 1.48 | 1.9K | 195,400 | D | ↗ |
| 2025-06-10 | Jackson Benjamin | Officer | S-Sale | D | Class A Common Stock | 965 | 1.48 | 1.4K | 134,198 | D | ↗ |
| 2025-06-10 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 667 | 1.48 | 987.16 | 114,539 | D | ↗ |
| 2025-06-10 | Boniface John J. | Officer | S-Sale | D | Class A Common Stock | 1,439 | 1.48 | 2.1K | 167,982 | D | ↗ |
| 2025-06-10 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 945 | 1.48 | 1.4K | 296,648 | D | ↗ |
| 2025-06-09 | Lindgardt Zhenya | Director / Officer | S-Sale | D | Class A Common Stock | 23,042 | 1.43 | 33.0K | 844,209 | D | ↗ |
| 2025-06-09 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 5,735 | 1.43 | 8.2K | 297,593 | D | ↗ |
| 2025-06-06 | Mirza Mansoor Raza | Director | S-Sale | D | Class A Common Stock | 107 | 1.58 | 169.06 | 59,161 | D | ↗ |
| 2025-06-05 | Wilson Marcus Dean | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-06-05 | Trimble Ryan | Director | A-Award | A | Class A Common Stock | 15,596 | 0.00 | — | 22,713 | D | ↗ |
| 2025-06-05 | Phillips Joshua | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 1.60 | 40.0K | 25,000 | D | ↗ |
| 2025-06-05 | Mirza Mansoor Raza | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 1.60 | 40.0K | 25,000 | D | ↗ |
| 2025-06-05 | Lawrence Sandra AJ | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 1.60 | 40.0K | 25,000 | D | ↗ |
| 2025-06-05 | Kamdar Kim P. | Director | A-Award | A | Class A Common Stock | 15,596 | 0.00 | — | 29,342 | D | ↗ |
| 2025-06-05 | CRITCHFIELD GREGORY C | Director | A-Award | A | Class A Common Stock | 15,596 | 0.00 | — | 822,866 | D | ↗ |
| 2025-06-05 | Barlow Jane F | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 1.60 | 40.0K | 25,000 | D | ↗ |
| 2025-05-30 | Jackson Benjamin | Officer | A-Award | A | Class A Common Stock | 3,703 | 1.33 | 4.9K | 135,163 | D | ↗ |
| 2025-05-30 | Boniface John J. | Officer | A-Award | A | Class A Common Stock | 3,703 | 1.33 | 4.9K | 169,421 | D | ↗ |
| 2025-05-19 | Anderson Dyaarl Lee Jr. | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-05-08 | Mirza Mansoor Raza | Director | S-Sale | D | Class A Common Stock | 106 | 2.44 | 258.64 | 43,672 | D | ↗ |
| 2025-05-08 | Lindgardt Zhenya | Director / Officer | S-Sale | D | Class A Common Stock | 9,406 | 2.44 | 23.0K | 867,251 | D | ↗ |
| 2025-05-08 | Kearney Paul | Officer | S-Sale | D | Class A Common Stock | 7,089 | 2.44 | 17.3K | 196,711 | D | ↗ |
| 2025-05-08 | Jackson Benjamin | Officer | S-Sale | D | Class A Common Stock | 7,084 | 2.44 | 17.3K | 131,460 | D | ↗ |
| 2025-05-08 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 6,551 | 2.44 | 16.0K | 115,206 | D | ↗ |
| 2025-05-08 | Boniface John J. | Officer | S-Sale | D | Class A Common Stock | 5,132 | 2.44 | 12.5K | 165,718 | D | ↗ |
| 2025-05-08 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 6,374 | 2.44 | 15.6K | 303,328 | D | ↗ |
| 2025-04-07 | Mirza Mansoor Raza | Director | S-Sale | D | Class A Common Stock | 107 | 3.35 | 358.45 | 43,778 | D | ↗ |
| 2025-03-20 | Elliott Jeffrey Thomas | Director | A-Award | A | Stock Option (right to buy) | 47,363 | 3.93 | 186.1K | 47,363 | D | ↗ |
| 2025-03-07 | Lindgardt Zhenya | Director / Officer | S-Sale | D | Class A Common Stock | 29,722 | 4.12 | 122.5K | 876,657 | D | ↗ |
| 2025-03-07 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 3,874 | 4.16 | 16.1K | 121,757 | D | ↗ |
| 2025-03-07 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 4,818 | 4.12 | 19.9K | 309,702 | D | ↗ |
| 2025-03-06 | Mirza Mansoor Raza | Director | S-Sale | D | Class A Common Stock | 99 | 4.16 | 411.84 | 43,885 | D | ↗ |
| 2025-03-06 | Lindgardt Zhenya | Director / Officer | A-Award | A | Class A Common Stock | 126,920 | 0.00 | — | 906,379 | D | ↗ |
| 2025-03-06 | Kearney Paul | Officer | S-Sale | D | Class A Common Stock | 1,338 | 4.16 | 5.6K | 203,800 | D | ↗ |
| 2025-03-06 | Jackson Benjamin | Officer | S-Sale | D | Class A Common Stock | 2,285 | 4.16 | 9.5K | 138,544 | D | ↗ |
| 2025-03-06 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 3,251 | 4.16 | 13.5K | 125,631 | D | ↗ |
| 2025-03-06 | Boniface John J. | Officer | S-Sale | D | Class A Common Stock | 2,044 | 4.16 | 8.5K | 170,850 | D | ↗ |
| 2025-03-06 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 540 | 4.16 | 2.2K | 314,520 | D | ↗ |
| 2025-03-05 | Kearney Paul | Officer | A-Award | A | Class A Common Stock | 47,010 | 0.00 | — | 205,138 | D | ↗ |
| 2025-03-05 | Jackson Benjamin | Officer | A-Award | A | Stock Option (right to buy) | 49,420 | 4.20 | 207.6K | 49,420 | D | ↗ |
| 2025-03-05 | Harrison Robert Gardner | Officer | A-Award | A | Stock Option (right to buy) | 36,830 | 4.20 | 154.7K | 36,830 | D | ↗ |
| 2025-03-05 | Boniface John J. | Officer | A-Award | A | Class A Common Stock | 47,010 | 0.00 | — | 172,894 | D | ↗ |
| 2025-03-05 | Aerts Austin | Officer | A-Award | A | Stock Option (right to buy) | 53,810 | 4.20 | 226.0K | 53,810 | D | ↗ |
| 2025-02-13 | Jackson Benjamin | Officer | S-Sale | D | Class A Common Stock | 5,915 | 4.58 | 27.1K | 106,239 | D | ↗ |
| 2025-02-13 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 3,610 | 4.28 | 15.5K | 103,112 | D | ↗ |
| 2025-02-12 | Mirza Mansoor Raza | Director | S-Sale | D | Class A Common Stock | 101 | 4.58 | 462.58 | 43,984 | D | ↗ |
| 2025-02-12 | Lindgardt Zhenya | Director / Officer | S-Sale | D | Class A Common Stock | 14,075 | 4.58 | 64.5K | 779,459 | D | ↗ |
| 2025-02-12 | Kearney Paul | Officer | S-Sale | D | Class A Common Stock | 5,342 | 4.58 | 24.5K | 158,128 | D | ↗ |
| 2025-02-12 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 7,297 | 4.58 | 33.4K | 106,722 | D | ↗ |
| 2025-02-12 | Boniface John J. | Officer | S-Sale | D | Class A Common Stock | 5,915 | 4.58 | 27.1K | 125,884 | D | ↗ |
| 2025-02-12 | BAKER BROS. ADVISORS LP | 10% Owner | — | — | Pre-Funded Warrants | 10,304,453 | 0.00 | 1.0K | 0 | I | ↗ |
| 2025-02-12 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 5,915 | 4.58 | 27.1K | 277,410 | D | ↗ |
| 2025-02-11 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 554 | 3.97 | 2.2K | 114,019 | D | ↗ |
| 2025-01-27 | Mirza Mansoor Raza | Director | M-Exempt | A | Class A Common Stock | 37,549 | 0.91 | 34.2K | 44,085 | D | ↗ |
| 2025-01-14 | Phillips Joshua | Director | S-Sale | D | Class A Common Stock | 2,695 | 6.29 | 17.0K | 0 | I | ↗ |
| 2025-01-14 | Jackson Benjamin | Officer | S-Sale | D | Class A Common Stock | 8,407 | 6.20 | 52.1K | 112,154 | D | ↗ |
| 2025-01-13 | Phillips Joshua | Director | S-Sale | D | Class A Common Stock | 3,458 | 6.39 | 22.1K | 2,695 | I | ↗ |
| 2025-01-13 | Jackson Benjamin | Officer | S-Sale | D | Class A Common Stock | 7,912 | 6.38 | 50.5K | 120,561 | D | ↗ |
| 2025-01-13 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 2,264 | 6.47 | 14.6K | 114,573 | D | ↗ |
| 2025-01-10 | Phillips Joshua | Director | S-Sale | D | Class A Common Stock | 643 | 8.03 | 5.2K | 4,229 | I | ↗ |
| 2025-01-10 | Kearney Paul | Officer | S-Sale | D | Class A Common Stock | 12,275 | 7.36 | 90.3K | 164,614 | D | ↗ |
| 2025-01-10 | Jackson Benjamin | Officer | S-Sale | D | Class A Common Stock | 12,041 | 7.36 | 88.6K | 129,704 | D | ↗ |
| 2025-01-10 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 12,372 | 7.30 | 90.3K | 118,674 | D | ↗ |
| 2025-01-10 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 2,431 | 8.06 | 19.6K | 283,325 | D | ↗ |
| 2025-01-06 | Mirza Mansoor Raza | Director | S-Sale | D | Class A Common Stock | 100 | 7.69 | 769.00 | 6,536 | D | ↗ |
| 2024-12-10 | Lindgardt Zhenya | Director / Officer | S-Sale | D | Class A Common Stock | 26,224 | 7.41 | 194.3K | 793,534 | D | ↗ |
| 2024-12-10 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 5,730 | 7.41 | 42.5K | 285,756 | D | ↗ |
| 2024-12-06 | Mirza Mansoor Raza | Director | S-Sale | D | Class A Common Stock | 93 | 7.12 | 662.16 | 6,636 | D | ↗ |
| 2024-11-11 | Mirza Mansoor Raza | Director | S-Sale | D | Class A Common Stock | 95 | 7.32 | 695.40 | 6,729 | D | ↗ |
| 2024-11-11 | Lindgardt Zhenya | Director / Officer | S-Sale | D | Class A Common Stock | 12,075 | 7.32 | 88.4K | 819,758 | D | ↗ |
| 2024-11-11 | Kearney Paul | Officer | S-Sale | D | Class A Common Stock | 4,078 | 7.32 | 29.9K | 176,889 | D | ↗ |
| 2024-11-11 | Jackson Benjamin | Officer | S-Sale | D | Class A Common Stock | 4,727 | 7.32 | 34.6K | 135,528 | D | ↗ |
| 2024-11-11 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 4,727 | 7.32 | 34.6K | 131,046 | D | ↗ |
| 2024-11-11 | Boniface John J. | Officer | S-Sale | D | Class A Common Stock | 4,727 | 7.32 | 34.6K | 125,120 | D | ↗ |
| 2024-11-11 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 7,179 | 7.32 | 52.6K | 291,486 | D | ↗ |
| 2024-10-07 | Mirza Mansoor Raza | Director | S-Sale | D | Class A Common Stock | 96 | 7.15 | 686.40 | 6,824 | D | ↗ |
| 2024-09-10 | Lindgardt Zhenya | Director / Officer | S-Sale | D | Class A Common Stock | 25,085 | 7.57 | 189.9K | 831,833 | — | ↗ |
| 2024-09-10 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 5,056 | 7.57 | 38.3K | 298,665 | — | ↗ |
| 2024-09-06 | Mirza Mansoor Raza | Director | S-Sale | D | Class A Common Stock | 96 | 7.16 | 687.36 | 6,920 | — | ↗ |
| 2024-08-07 | Mirza Mansoor Raza | Director | S-Sale | D | Class A Common Stock | 101 | 7.42 | 749.42 | 7,016 | — | ↗ |
| 2024-08-07 | Lindgardt Zhenya | Director / Officer | S-Sale | D | Class A Common Stock | 12,327 | 7.42 | 91.5K | 856,918 | — | ↗ |
| 2024-08-07 | Kearney Paul | Officer | S-Sale | D | Class A Common Stock | 4,333 | 7.42 | 32.2K | 180,967 | — | ↗ |
| 2024-08-07 | Jackson Benjamin | Officer | S-Sale | D | Class A Common Stock | 5,022 | 7.42 | 37.3K | 140,255 | — | ↗ |
| 2024-08-07 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 5,022 | 7.42 | 37.3K | 135,773 | — | ↗ |
| 2024-08-07 | Boniface John J. | Officer | S-Sale | D | Class A Common Stock | 5,022 | 7.42 | 37.3K | 129,847 | — | ↗ |
| 2024-08-07 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 6,760 | 7.42 | 50.2K | 303,721 | — | ↗ |
| 2024-07-13 | Wilson Marcus Dean | Director | A-Award | A | Stock Option (right to buy) | 10,549 | 8.43 | 88.9K | 10,549 | — | ↗ |
| 2024-06-10 | Lindgardt Zhenya | Director / Officer | S-Sale | D | Class A Common Stock | 26,867 | 8.11 | 217.9K | 869,245 | — | ↗ |
| 2024-06-10 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 5,415 | 8.11 | 43.9K | 310,481 | — | ↗ |
| 2024-06-06 | Trimble Ryan | Director | A-Award | A | Class A Common Stock | 7,117 | 0.00 | — | 7,117 | — | ↗ |
| 2024-06-06 | Phillips Joshua | Director | A-Award | A | Stock Option (right to buy) | 10,549 | 8.43 | 88.9K | 10,549 | — | ↗ |
| 2024-06-06 | Mirza Mansoor Raza | Director | A-Award | A | Class A Common Stock | 7,117 | 0.00 | — | 7,117 | — | ↗ |
| 2024-06-06 | Lawrence Sandra AJ | Director | A-Award | A | Class A Common Stock | 7,117 | 0.00 | — | 7,117 | — | ↗ |
| 2024-06-06 | Kamdar Kim P. | Director | A-Award | A | Class A Common Stock | 7,117 | 0.00 | — | 13,746 | — | ↗ |
| 2024-06-06 | CRITCHFIELD GREGORY C | Director | A-Award | A | Stock Option (right to buy) | 10,549 | 8.43 | 88.9K | 10,549 | — | ↗ |
| 2024-06-06 | Barlow Jane F | Director | A-Award | A | Class A Common Stock | 7,117 | 0.00 | — | 7,117 | — | ↗ |
| 2024-06-03 | Phillips Joshua | Director | J-Other | D | Class A Common Stock | 356,660 | 0.00 | — | 17,684 | — | ↗ |
| 2024-06-03 | CRITCHFIELD GREGORY C | Director | J-Other | A | Class A Common Stock | 195 | 0.00 | — | 800,140 | — | ↗ |
| 2024-05-15 | Kearney Paul | Officer | S-Sale | D | Class A Common Stock | 10,387 | 8.24 | 85.6K | 185,300 | — | ↗ |
| 2024-05-10 | Kearney Paul | Officer | A-Award | A | Class A Common Stock | 40,854 | 0.00 | — | 195,687 | — | ↗ |
| 2024-05-08 | Lindgardt Zhenya | Director / Officer | S-Sale | D | Class A Common Stock | 11,992 | 9.59 | 115.0K | 896,112 | — | ↗ |
| 2024-05-08 | Kearney Paul | Officer | S-Sale | D | Class A Common Stock | 4,205 | 9.59 | 40.3K | 154,833 | — | ↗ |
| 2024-05-08 | Jackson Benjamin | Officer | S-Sale | D | Class A Common Stock | 4,902 | 9.59 | 47.0K | 145,277 | — | ↗ |
| 2024-05-08 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 4,902 | 9.59 | 47.0K | 140,795 | — | ↗ |
| 2024-05-08 | Boniface John J. | Officer | S-Sale | D | Class A Common Stock | 4,902 | 9.59 | 47.0K | 134,869 | — | ↗ |
| 2024-05-08 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 6,592 | 9.59 | 63.2K | 315,896 | — | ↗ |
| 2024-03-28 | Boniface John J. | Officer | S-Sale | D | Class A Common Stock | 24,474 | 9.04 | 221.2K | 139,771 | — | ↗ |
| 2024-03-27 | Boniface John J. | Officer | M-Exempt | D | Stock Option (right to buy) | 48,909 | 0.91 | 44.5K | 24,474 | — | ↗ |
| 2024-03-26 | Lindgardt Zhenya | Director / Officer | S-Sale | D | Class A Common Stock | 38,899 | 9.37 | 364.5K | 908,104 | — | ↗ |
| 2024-03-26 | Boniface John J. | Officer | S-Sale | D | Class A Common Stock | 21,438 | 9.55 | 204.7K | 143,524 | — | ↗ |
| 2024-03-26 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 8,092 | 9.37 | 75.8K | 322,488 | — | ↗ |
| 2024-03-25 | Boniface John J. | Officer | S-Sale | D | Class A Common Stock | 22,163 | 9.10 | 201.7K | 164,962 | — | ↗ |
| 2024-03-06 | Kearney Paul | Officer | S-Sale | D | Class A Common Stock | 1,028 | 9.02 | 9.3K | 159,038 | — | ↗ |
| 2024-03-06 | Jackson Benjamin | Officer | S-Sale | D | Class A Common Stock | 1,856 | 9.02 | 16.7K | 150,179 | — | ↗ |
| 2024-03-06 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 2,138 | 9.02 | 19.3K | 145,697 | — | ↗ |
| 2024-03-06 | Boniface John J. | Officer | S-Sale | D | Class A Common Stock | 1,664 | 9.02 | 15.0K | 187,125 | — | ↗ |
| 2024-03-06 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 444 | 9.02 | 4.0K | 330,580 | — | ↗ |
| 2024-02-06 | Lindgardt Zhenya | Director / Officer | S-Sale | D | Class A Common Stock | 27,997 | 8.03 | 224.8K | 947,003 | — | ↗ |
| 2024-02-06 | Kearney Paul | Officer | S-Sale | D | Class A Common Stock | 4,984 | 8.03 | 40.0K | 160,066 | — | ↗ |
| 2024-02-06 | Jackson Benjamin | Officer | S-Sale | D | Class A Common Stock | 5,665 | 8.03 | 45.5K | 152,035 | — | ↗ |
| 2024-02-06 | Harrison Robert Gardner | Officer | S-Sale | D | Class A Common Stock | 5,665 | 8.03 | 45.5K | 147,835 | — | ↗ |
| 2024-02-06 | Boniface John J. | Officer | S-Sale | D | Class A Common Stock | 5,665 | 8.03 | 45.5K | 188,789 | — | ↗ |
| 2024-02-06 | Aerts Austin | Officer | S-Sale | D | Class A Common Stock | 9,786 | 8.03 | 78.6K | 331,024 | — | ↗ |
| 2023-12-07 | Jackson Benjamin | Officer | S-Sale | D | Class A Common Stock | 10,000 | 5.22 | 52.2K | 157,700 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-5.8K
Shares Outstanding
38.19M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Zhenya Lindgardt President and Chief Executive Officer | 607.0K | — | 526.7K | 494.0K | 392.1K | 14.0K | 2.03M | 50.19% | ↗ |
| 2 | 2025 | John J. Boniface, Ph.D. Chief Scientific Officer | 439.1K | — | 197.4K | 187.0K | 166.7K | 14.0K | 1.00M | 38.28% | ↗ |
| 3 | 2025 | Paul Kearney, Ph.D. Chief Data Officer | 426.1K | — | 197.4K | 187.0K | 160.2K | 14.0K | 984.7K | 39.04% | ↗ |
| 4 | 2024 | Paul Kearney, Ph.D. Chief Data Officer | 391.3K | — | 378.3K | — | 63.6K | 13.8K | 847.0K | 44.66% | ↗ |
| 5 | 2024 | Zhenya Lindgardt President and Chief Executive Officer | 447.3K | — | — | — | 232.3K | 13.8K | 693.4K | 0.00% | ↗ |
| 6 | 2024 | John J. Boniface, Ph.D. Chief Scientific Officer | 358.9K | — | — | — | 58.6K | 13.8K | 431.3K | 0.00% | ↗ |
| 7 | 2023 | Zhenya Lindgardt President and Chief Executive Officer | 303.0K | — | 1.81M | — | 57.2K | 22.6K | 2.20M | 82.57% | ↗ |
| 8 | 2023 | Gregory C. Critchfield, M.D., M.S. Former Chairman, President, and Chief Executive Officer | 313.0K | — | 231.4K | 243.0K | 131.4K | 594.0K | 1.51M | 31.36% | ↗ |
| 9 | 2023 | Austin Aerts Chief Financial Officer | 307.6K | — | 645.2K | 23.2K | 46.8K | 13.2K | 1.04M | 64.51% | ↗ |
| 10 | 2023 | John J. Boniface, Ph.D. Chief Scientific Officer | 398.5K | — | 316.5K | 88.2K | 55.6K | 13.2K | 872.0K | 46.41% | ↗ |
| 11 | 2023 | Paul Kearney, Ph.D. Chief Data Officer | 407.4K | — | 293.3K | 63.9K | 56.9K | 12.4K | 834.0K | 42.83% | ↗ |
| 12 | 2022 | Gregory C. Critchfield, M.D., M.S. Chairman, President, and Chief Executive Officer | 584.0K | 2.98M | — | — | — | — | 3.56M | 0.00% | ↗ |
| 13 | 2022 | Michael R. Foley, M.D. Chief Medical Officer | 428.4K | 2.86M | — | — | — | — | 3.29M | 0.00% | ↗ |
| 14 | 2022 | Jay Moyes Chief Financial Officer | 421.1K | 1.47M | — | — | — | — | 1.89M | 0.00% | ↗ |
| 15 | 2022 | Gregory C. Critchfield, M.D., M.S. Former Chairman, President, and Chief Executive Officer | 584.0K | — | — | 989.6K | 206.7K | — | 1.78M | 55.59% | ↗ |
| 16 | 2022 | John J. Boniface, Ph.D. Chief Scientific Officer | 406.1K | — | — | 280.8K | 127.2K | 12.2K | 826.2K | 33.98% | ↗ |
| 17 | 2022 | Austin Aerts Chief Financial Officer | 230.2K | — | — | 91.1K | 57.5K | 10.7K | 389.4K | 23.39% | ↗ |
| 18 | 2022 | Zhenya Lindgardt President and Chief Executive Officer | — | — | — | 120.0K | — | 37.5K | 157.5K | 76.19% | ↗ |
| 19 | 2021 | Gregory C. Critchfield, M.D., M.S. Chairman, President, and Chief Executive Officer | 500.1K | 1.96M | — | — | — | — | 2.46M | 0.00% | ↗ |
| 20 | 2021 | Robert G. Harrison Chief Information Officer | 238.8K | — | — | 1.60M | 67.8K | — | 1.91M | 83.94% | ↗ |
| 21 | 2021 | Jay Moyes Chief Financial Officer | 380.1K | 1.51M | — | — | — | — | 1.89M | 0.00% | ↗ |
| 22 | 2021 | Benjamin G. Jackson General Counsel | 223.3K | — | — | 1.29M | 100.4K | — | 1.62M | 79.99% | ↗ |
| 23 | 2021 | Michael R. Foley, M.D. Chief Medical Officer | — | 20.0K | — | — | — | — | 20.0K | 0.00% | ↗ |
| 24 | 2020 | Gregory C. Critchfield, M.D., M.S. Chairman, President, and Chief Executive Officer | 400.0K | — | — | 408.9K | 144.0K | — | 952.9K | 42.91% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Zhenya Lindgardt | President, Chief Executive Officer & Director | 1M | female |
| John J. Boniface | Chief Scientific Officer | 619.8K | — |
| Paul Kearney | Chief Data Officer | 600.3K | — |
| Tiffany Inglis FACOG | Chief Medical Officer | 575.5K | — |
| Benjamin G. Jackson | General Counsel & Corporate Secretary | 410.8K | male |
| Robert G. Harrison | Chief Information Officer | 384.2K | male |
| Austin Aerts | Chief Financial Officer | 367.6K | male |
| Gregory C. Critchfield | Executive Director | 35.0K | — |
| Lee Anderson | Chief Commercial Officer | — | male |
| Jennifer Zibuda | Head of Investor Relations | — | female |
| Chuck Hyde | Head of Market Access | — | male |
ESG Rating
ESG Score History MEDICAL - DIAGNOSTICS & RESEARCH
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SERA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
